Successful cancer therapy depends on an optimal immune response, but noninvasive tools are lacking to monitor this dynamic process. In this proof-of-concept human study, we demonstrated hyperpolarized [1-13C]pyruvate MRI of the spleen monitoring the immune activation for cancer patients at the early time point following radiotherapy, by measuring the pyruvate-to-lactate conversion rate. The ADC-based cellularity of the spleen, however, did not detect remarkable changes.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords